Literature DB >> 3782466

Osteogenesis imperfecta type IV. Biochemical confirmation of genetic linkage to the pro alpha 2(I) gene of type I collagen.

R J Wenstrup, P Tsipouras, P H Byers.   

Abstract

Fibroblasts from two affected members of a large pedigree in which osteogenesis imperfecta (OI) type IV is genetically linked to the pro alpha 2(I) gene of type I collagen synthesize two populations of pro alpha 2(I) chains. One population is normal; the second population appears to have a deletion of about 10 amino acid residues from the middle of the triple helical domain. The mutation in pro alpha 2(I) causes increased posttranslational modification in the amino-terminal half of some pro alpha 1(I) chains, lowers the melting temperature of type I collagen molecules that incorporate a mutant pro alpha 2(I) chain, and prevents or delays the secretion of those molecules from fibroblasts in cell culture. On the basis of this study and linkage studies in additional families, it appears that the OI type IV phenotype is often the result of heterozygosity for mutations in pro alpha 2(I) that alter the triple helical structure of type I collagen.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3782466      PMCID: PMC423890          DOI: 10.1172/JCI112735

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  39 in total

1.  Quantitative film detection of 3H and 14C in polyacrylamide gels by fluorography.

Authors:  R A Laskey; A D Mills
Journal:  Eur J Biochem       Date:  1975-08-15

2.  Human skin fibroblast collagenase: chemical properties of precursor and active forms.

Authors:  G P Stricklin; A Z Eisen; E A Bauer; J J Jeffrey
Journal:  Biochemistry       Date:  1978-06-13       Impact factor: 3.162

3.  The thermal transition of a non-hydroxylated form of collagen. Evidence for a role for hydroxyproline in stabilizing the triple-helix of collagen.

Authors:  R A Berg; D J Prockop
Journal:  Biochem Biophys Res Commun       Date:  1973-05-01       Impact factor: 3.575

4.  A film detection method for tritium-labelled proteins and nucleic acids in polyacrylamide gels.

Authors:  W M Bonner; R A Laskey
Journal:  Eur J Biochem       Date:  1974-07-01

5.  Collagen heterogeneity within different growth regions of long bones of rachitic and non-rachitic chicks.

Authors:  B P Toole; A H Kang; R L Trelstad; J Gross
Journal:  Biochem J       Date:  1972-05       Impact factor: 3.857

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  Genetic heterogeneity in osteogenesis imperfecta.

Authors:  D O Sillence; A Senn; D M Danks
Journal:  J Med Genet       Date:  1979-04       Impact factor: 6.318

8.  Bone collagen metabolism in vitamin D deficiency.

Authors:  M J Barnes; B J Constable; L F Morton; E Kodicek
Journal:  Biochem J       Date:  1973-01       Impact factor: 3.857

9.  Thermal stability of type I and type III procollagens from normal human fibroblasts and from a patient with osteogenesis imperfecta.

Authors:  L Peltonen; A Palotie; T Hayashi; D J Prockop
Journal:  Proc Natl Acad Sci U S A       Date:  1980-01       Impact factor: 11.205

10.  Osteogenesis imperfecta type IV: evidence of abnormal triple helical structure of type I collagen.

Authors:  R J Wenstrup; A G Hunter; P H Byers
Journal:  Hum Genet       Date:  1986-09       Impact factor: 4.132

View more
  8 in total

1.  Segregation analysis of dominant osteogenesis imperfecta in Italy.

Authors:  M Mottes; L Cugola; N Cappello; P F Pignatti
Journal:  J Med Genet       Date:  1990-06       Impact factor: 6.318

2.  Cloning and chromosomal localization of human genes encoding the three chains of type VI collagen.

Authors:  D Weil; M G Mattei; E Passage; V C N'Guyen; D Pribula-Conway; K Mann; R Deutzmann; R Timpl; M L Chu
Journal:  Am J Hum Genet       Date:  1988-03       Impact factor: 11.025

3.  A lethal variant of osteogenesis imperfecta has a single base mutation that substitutes cysteine for glycine 904 of the alpha 1(I) chain of type I procollagen. The asymptomatic mother has an unidentified mutation producing an overmodified and unstable type I procollagen.

Authors:  C D Constantinou; K B Nielsen; D J Prockop
Journal:  J Clin Invest       Date:  1989-02       Impact factor: 14.808

4.  Cysteine in the triple helical domain of the pro alpha 2(I) chain of type-I collagen in nonlethal forms of osteogenesis imperfecta.

Authors:  D H Cohn; P H Byers
Journal:  Hum Genet       Date:  1991-06       Impact factor: 4.132

5.  Clinical variability of osteogenesis imperfecta linked to COL1A2 and associated with a structural defect in the type I collagen molecule.

Authors:  A Superti-Furga; F Pistone; C Romano; B Steinmann
Journal:  J Med Genet       Date:  1989-06       Impact factor: 6.318

6.  Frameshift mutation near the 3' end of the COL1A1 gene of type I collagen predicts an elongated Pro alpha 1(I) chain and results in osteogenesis imperfecta type I.

Authors:  M C Willing; D H Cohn; P H Byers
Journal:  J Clin Invest       Date:  1990-01       Impact factor: 14.808

7.  Prenatal prediction of osteogenesis imperfecta (OI type IV): exclusion of inheritance using a collagen gene probe.

Authors:  P Tsipouras; R C Schwartz; J D Goldberg; R L Berkowitz; F Ramirez
Journal:  J Med Genet       Date:  1987-07       Impact factor: 6.318

8.  Osteogenesis imperfecta. The position of substitution for glycine by cysteine in the triple helical domain of the pro alpha 1(I) chains of type I collagen determines the clinical phenotype.

Authors:  B J Starman; D Eyre; H Charbonneau; M Harrylock; M A Weis; L Weiss; J M Graham; P H Byers
Journal:  J Clin Invest       Date:  1989-10       Impact factor: 14.808

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.